Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Metachronous Isolated Splenic Metastasis in a Young Patient With Renal Cell Carcinoma: Case Report and Literature Review.

Costantini M, Tuderti G, Minisola F, Pompeo V, Sentinelli S, Amoreo CA, Vallati G, Poeta ML, Gallucci M, Simone G.

Urology. 2019 May;127:13-18. doi: 10.1016/j.urology.2019.01.007. Epub 2019 Jan 16.

PMID:
30659899
2.

EphB2 stem-related and EphA2 progression-related miRNA-based networks in progressive stages of CRC evolution: clinical significance and potential miRNA drivers.

De Robertis M, Mazza T, Fusilli C, Loiacono L, Poeta ML, Sanchez M, Massi E, Lamorte G, Diodoro MG, Pescarmona E, Signori E, Pesole G, Vescovi AL, Garcia-Foncillas J, Fazio VM.

Mol Cancer. 2018 Nov 30;17(1):169. doi: 10.1186/s12943-018-0912-z.

3.

Current understanding and clinical utility of miRNAs regulation of colon cancer stem cells.

De Robertis M, Poeta ML, Signori E, Fazio VM.

Semin Cancer Biol. 2018 Dec;53:232-247. doi: 10.1016/j.semcancer.2018.08.008. Epub 2018 Aug 18. Review.

PMID:
30130662
4.

Integrated transcriptomic and epigenomic analysis of ovarian cancer reveals epigenetically silenced GULP1.

Maldonado L, Brait M, Izumchenko E, Begum S, Chatterjee A, Sen T, Loyo M, Barbosa A, Poeta ML, Makarev E, Zhavoronkov A, Fazio VM, Angioli R, Rabitti C, Ongenaert M, Van Criekinge W, Noordhuis MG, de Graeff P, Wisman GBA, van der Zee AGJ, Hoque MO.

Cancer Lett. 2018 Oct 1;433:242-251. doi: 10.1016/j.canlet.2018.06.030. Epub 2018 Jun 28.

PMID:
29964205
5.

Alpha-1 Antitrypsin Deficiency: Current Perspective from Genetics to Diagnosis and Therapeutic Approaches.

Santangelo S, Scarlata S, Poeta ML, Bialas AJ, Paone G, Incalzi RA.

Curr Med Chem. 2017;24(1):65-90. doi: 10.2174/0929867324666161118125827. Review.

PMID:
27855621
6.

Dysregulation of EGFR Pathway in EphA2 Cell Subpopulation Significantly Associates with Poor Prognosis in Colorectal Cancer.

De Robertis M, Loiacono L, Fusilli C, Poeta ML, Mazza T, Sanchez M, Marchionni L, Signori E, Lamorte G, Vescovi AL, Garcia-Foncillas J, Fazio VM.

Clin Cancer Res. 2017 Jan 1;23(1):159-170. doi: 10.1158/1078-0432.CCR-16-0709. Epub 2016 Jul 11.

7.

Collecting duct carcinoma of the kidney is associated with CDKN2A deletion and SLC family gene up-regulation.

Wang J, Papanicolau-Sengos A, Chintala S, Wei L, Liu B, Hu Q, Miles KM, Conroy JM, Glenn ST, Costantini M, Magi-Galluzzi C, Signoretti S, Choueiri T, Gallucci M, Sentinelli S, Fazio VM, Poeta ML, Liu S, Morrison C, Pili R.

Oncotarget. 2016 May 24;7(21):29901-15. doi: 10.18632/oncotarget.9093.

8.

Evaluation of microRNA-10b prognostic significance in a prospective cohort of breast cancer patients.

Parrella P, Barbano R, Pasculli B, Fontana A, Copetti M, Valori VM, Poeta ML, Perrone G, Righi D, Castelvetere M, Coco M, Balsamo T, Morritti M, Pellegrini F, Onetti-Muda A, Maiello E, Murgo R, Fazio VM.

Mol Cancer. 2014 Jun 4;13:142. doi: 10.1186/1476-4598-13-142.

9.

Association of promoter methylation of VGF and PGP9.5 with ovarian cancer progression.

Brait M, Maldonado L, Noordhuis MG, Begum S, Loyo M, Poeta ML, Barbosa A, Fazio VM, Angioli R, Rabitti C, Marchionni L, de Graeff P, van der Zee AG, Wisman GB, Sidransky D, Hoque MO.

PLoS One. 2013 Sep 27;8(9):e70878. doi: 10.1371/journal.pone.0070878. eCollection 2013. Erratum in: PLoS One. 2013;8(10). doi:10.1371/annotation/ccd51e37-fdf3-466e-b79f-2c390df9ab28. PLoS One. 2013;8(10). doi:10.1371/annotation/5d2e13d4-cb4e-44b1-a836-dff9b4144b5b. Noordhuis, Maartje [corrected to Noordhuis, Maartje G].

10.

Aberrant Keap1 methylation in breast cancer and association with clinicopathological features.

Barbano R, Muscarella LA, Pasculli B, Valori VM, Fontana A, Coco M, la Torre A, Balsamo T, Poeta ML, Marangi GF, Maiello E, Castelvetere M, Pellegrini F, Murgo R, Fazio VM, Parrella P.

Epigenetics. 2013 Jan;8(1):105-12. doi: 10.4161/epi.23319. Epub 2012 Dec 18.

11.

Aberrant genes promoter methylation in neural crest-derived tumors.

la Torre A, Muscarella LA, Parrella P, Balsamo T, Bisceglia M, Valori VM, la Torre A, Barbano R, Perrella E, Poeta ML, Melchionda G, Merla G, Maiello E, Pellicano R, Fazio VM.

Int J Biol Markers. 2012 Dec 27;27(4):e389-94. doi: 10.5301/JBM.2012.9766.

PMID:
23125005
12.

Aberrant promoter methylation of beta-1,4 galactosyltransferase 1 as potential cancer-specific biomarker of colorectal tumors.

Poeta ML, Massi E, Parrella P, Pellegrini P, De Robertis M, Copetti M, Rabitti C, Perrone G, Muda AO, Molinari F, Zanellato E, Crippa S, Caputo D, Caricato M, Frattini M, Coppola R, Fazio VM.

Genes Chromosomes Cancer. 2012 Dec;51(12):1133-43. doi: 10.1002/gcc.21998. Epub 2012 Aug 25.

PMID:
22927297
13.

The AOM/DSS murine model for the study of colon carcinogenesis: From pathways to diagnosis and therapy studies.

De Robertis M, Massi E, Poeta ML, Carotti S, Morini S, Cecchetelli L, Signori E, Fazio VM.

J Carcinog. 2011 Mar 24;10:9. doi: 10.4103/1477-3163.78279.

14.

Genetic and epigenetic analysis of erbB signaling pathway genes in lung cancer.

Hoque MO, Brait M, Rosenbaum E, Poeta ML, Pal P, Begum S, Dasgupta S, Carvalho AL, Ahrendt SA, Westra WH, Sidransky D.

J Thorac Oncol. 2010 Dec;5(12):1887-93. doi: 10.1097/JTO.0b013e3181f77a53. Erratum in: J Thorac Oncol. 2011 Feb;6(2):409.

15.

The Ligamp TP53 Assay for Detection of Minimal Residual Disease in Head and Neck Squamous Cell Carcinoma Surgical Margins.

Poeta ML, Manola J, Goldenberg D, Forastiere A, Califano JA, Ridge JA, Goodwin J, Kenady D, Saunders J, Westra W, Sidransky D, Koch WM.

Clin Cancer Res. 2009 Dec 15;15(24):7658-7665.

16.

Bilateral consecutive rupture of the quadriceps tendon in a man with BstUI polymorphism of the COL5A1 gene.

Longo UG, Fazio V, Poeta ML, Rabitti C, Franceschi F, Maffulli N, Denaro V.

Knee Surg Sports Traumatol Arthrosc. 2010 Apr;18(4):514-8. doi: 10.1007/s00167-009-1002-y. Epub 2009 Dec 3.

PMID:
19956930
17.

Changes in CpG islands promoter methylation patterns during ductal breast carcinoma progression.

Hoque MO, Prencipe M, Poeta ML, Barbano R, Valori VM, Copetti M, Gallo AP, Brait M, Maiello E, Apicella A, Rossiello R, Zito F, Stefania T, Paradiso A, Carella M, Dallapiccola B, Murgo R, Carosi I, Bisceglia M, Fazio VM, Sidransky D, Parrella P.

Cancer Epidemiol Biomarkers Prev. 2009 Oct;18(10):2694-700. doi: 10.1158/1055-9965.EPI-08-0821. Epub 2009 Sep 29.

18.

High specificity of quantitative methylation-specific PCR analysis for MGMT promoter hypermethylation detection in gliomas.

Parrella P, la Torre A, Copetti M, Valori VM, Barbano R, Notarangelo A, Bisceglia M, Gallo AP, Balsamo T, Poeta ML, Carella M, Catapano D, Parisi S, Dallapiccola B, Maiello E, D'Angelo V, Fazio VM.

J Biomed Biotechnol. 2009;2009:531692. doi: 10.1155/2009/531692. Epub 2009 Jun 1.

19.

Genome-wide promoter analysis uncovers portions of the cancer methylome.

Hoque MO, Kim MS, Ostrow KL, Liu J, Wisman GB, Park HL, Poeta ML, Jeronimo C, Henrique R, Lendvai A, Schuuring E, Begum S, Rosenbaum E, Ongenaert M, Yamashita K, Califano J, Westra W, van der Zee AG, Van Criekinge W, Sidransky D.

Cancer Res. 2008 Apr 15;68(8):2661-70. doi: 10.1158/0008-5472.CAN-07-5913.

20.

Inverse relationship between human papillomavirus-16 infection and disruptive p53 gene mutations in squamous cell carcinoma of the head and neck.

Westra WH, Taube JM, Poeta ML, Begum S, Sidransky D, Koch WM.

Clin Cancer Res. 2008 Jan 15;14(2):366-9. doi: 10.1158/1078-0432.CCR-07-1402.

21.

TP53 mutations and survival in squamous-cell carcinoma of the head and neck.

Poeta ML, Manola J, Goldwasser MA, Forastiere A, Benoit N, Califano JA, Ridge JA, Goodwin J, Kenady D, Saunders J, Westra W, Sidransky D, Koch WM.

N Engl J Med. 2007 Dec 20;357(25):2552-61.

22.

DNA end binding activity and Ku70/80 heterodimer expression in human colorectal tumor.

Mazzarelli P, Parrella P, Seripa D, Signori E, Perrone G, Rabitti C, Borzomati D, Gabbrielli A, Matera MG, Gravina C, Caricato M, Poeta ML, Rinaldi M, Valeri S, Coppola R, Fazio VM.

World J Gastroenterol. 2005 Nov 14;11(42):6694-700.

23.

HIC1 promoter methylation and 17p13.3 allelic loss in invasive ductal carcinoma of the breast.

Parrella P, Scintu M, Prencipe M, Poeta ML, Gallo AP, Rabitti C, Rinaldi M, Tommasi S, Paradiso A, Schittulli F, Valori VM, Toma S, Altomare V, Fazio VM.

Cancer Lett. 2005 May 10;222(1):75-81.

PMID:
15837543
24.

Nonrandom distribution of aberrant promoter methylation of cancer-related genes in sporadic breast tumors.

Parrella P, Poeta ML, Gallo AP, Prencipe M, Scintu M, Apicella A, Rossiello R, Liguoro G, Seripa D, Gravina C, Rabitti C, Rinaldi M, Nicol T, Tommasi S, Paradiso A, Schittulli F, Altomare V, Fazio VM.

Clin Cancer Res. 2004 Aug 15;10(16):5349-54.

25.

Anatomy of a wrong diagnosis: false sinus venosus atrial septal defect.

Gaibazzi N, Montresor G, Poeta ML.

Cardiovasc Ultrasound. 2003 Nov 7;1:15.

26.

Differential modulation of Ku70/80 DNA-binding activity in a patient with multiple basal cell carcinomas.

Mazzarelli P, Rabitti C, Parrella P, Seripa D, Persichetti P, Marangi GF, Perrone G, Poeta ML, Delfino M, Fazio VM.

J Invest Dermatol. 2003 Sep;121(3):628-33.

27.

[Long QRS tachycardia secondary to Aconitum napellus alkaloid ingestion].

Gaibazzi N, Gelmini GP, Montresor G, Canel D, Comini T, Fracalossi C, Martinetti C, Poeta ML, Ziacchi V.

Ital Heart J Suppl. 2002 Aug;3(8):874-7. Italian.

PMID:
12407844
28.

Cigarette smoking and sports participation in adolescents: a cross-sectional survey among high school students in Italy.

Donato F, Assanelli D, Chiesa R, Poeta ML, Tomasoni V, Turla C.

Subst Use Misuse. 1997 Sep;32(11):1555-72.

PMID:
9336865

Supplemental Content

Loading ...
Support Center